You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
24 September 2019
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for two medicines containing benzoyl peroxide – Galderma's Acnecide Face Gel and Acnecide Face Wash – to be switched from pharmacy (P) to general-sale list (GSL) status.
9 September 2019
The UK is reviewing ways of making high-dose statins available directly from pharmacies – without a doctor's prescription – as part of the National Health Service (NHS) Long Term Plan to cut heart disease.
22 August 2019
June Raine will become interim chief executive officer of the UK's Medicines and Healthcare products Regulatory Agency (MHRA) on 20 September 2019.
1 August 2019
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for a skin patch that screens for allergies to paraphenylenediamine (PPD) – a common component of hair colourants – to be switched from a prescription-only medicine to general-sale list (GSL) statu...
10 May 2019
Galderma is seeking to switch two medicines containing benzoyl peroxide – Acnecide Face Gel and Acnecide Face Wash – from pharmacy (P) to general-sale list (GSL) status in the UK.
7 May 2019
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has announced John Wilkinson will step down as director of devices at the end of October 2019.
13 December 2018
Teething gels for babies and children that contain the active ingredient lidocaine will be restricted to sale through pharmacies from 2019 in the UK.
20 November 2018
The UK's Medicines and Healthcare products Regulatory Agency (MHRA), Holland & Barrett International and Mundipharma have all recently announced people changes.
23 October 2018
A skin patch that screens for allergies to paraphenylenediamine – a common component of hair colourants that is also known as PPD or para – could soon be available without a prescription in the UK.
4 October 2018
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has opened a consultation on how its legislation and regulatory processes would have to be modified if the UK does not secure a deal with the European Union after its departure from the European Union and there is no implementation...